Back to Results
First PageMeta Content
Endocrine system / Androgens / Andrology / Medicine / RTT / Male genital disorders / Testosterone / Androgen replacement therapy / Hypogonadism / TAP Pharmaceuticals / Food and Drug Administration / Prostate cancer


Aytu BioScience Corporate Overview | August 2016 Safe Harbor Statement This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E o
Add to Reading List

Document Date: 2016-08-05 15:09:42


Open Document

File Size: 1,31 MB

Share Result on Facebook